Page last updated: 2024-09-04

ivabradine and Atrioventricular Block

ivabradine has been researched along with Atrioventricular Block in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Aimoto, M; Kawakami, S; Nagasawa, Y; Takahara, A	1
Bisht, DS; Gokhroo, RK; Gupta, S; Kishore, K; Priti, K; Ranwa, BL	1
Bobkov, Y; Boink, GJ; Cohen, IS; Danilo, P; Duan, L; Kryukova, Y; Nearing, BD; Robinson, RB; Rosen, MR; Shlapakova, IN; Tan, HL; Verrier, RL	1

Trials

1 trial(s) available for ivabradine and Atrioventricular Block

Article	Year
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine". Cardiovascular therapeutics, 2017, Volume: 35, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Block; Benzazepines; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Heart Block; Heart Failure; Humans; Inferior Wall Myocardial Infarction; Ivabradine; Male; Metoprolol; Middle Aged; Prospective Studies; Recurrence; Survival Analysis	2017

Article

Year

Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".

Cardiovascular therapeutics, 2017, Volume: 35, Issue:4

Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Block; Benzazepines; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Heart Block; Heart Failure; Humans; Inferior Wall Myocardial Infarction; Ivabradine; Male; Metoprolol; Middle Aged; Prospective Studies; Recurrence; Survival Analysis

2017

Other Studies

2 other study(ies) available for ivabradine and Atrioventricular Block

Article	Year
Torsadogenic Potential of HCN Channel Blocker Ivabradine Assessed in the Rabbit Proarrhythmia Model. Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:11 Topics: Animals; Atrioventricular Block; Cardiovascular Agents; Disease Models, Animal; Electrocardiography; Heart Rate; Hemodynamics; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Rabbits; Torsades de Pointes	2021
Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2. Circulation, 2012, Jul-31, Volume: 126, Issue:5 Topics: Adenoviridae; Adenylyl Cyclases; Animals; Atrioventricular Block; Benzazepines; Catheter Ablation; Circadian Rhythm; Dogs; Electrocardiography; Gene Transfer Techniques; Genetic Therapy; Heart Conduction System; Heart Rate; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Models, Animal; Potassium Channel Blockers	2012

Article

Year

Torsadogenic Potential of HCN Channel Blocker Ivabradine Assessed in the Rabbit Proarrhythmia Model.

Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:11

Topics: Animals; Atrioventricular Block; Cardiovascular Agents; Disease Models, Animal; Electrocardiography; Heart Rate; Hemodynamics; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Rabbits; Torsades de Pointes

2021

Ca(2+)-stimulated adenylyl cyclase AC1 generates efficient biological pacing as single gene therapy and in combination with HCN2.

Circulation, 2012, Jul-31, Volume: 126, Issue:5

Topics: Adenoviridae; Adenylyl Cyclases; Animals; Atrioventricular Block; Benzazepines; Catheter Ablation; Circadian Rhythm; Dogs; Electrocardiography; Gene Transfer Techniques; Genetic Therapy; Heart Conduction System; Heart Rate; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ion Channels; Ivabradine; Models, Animal; Potassium Channel Blockers

2012